Cptac biospecimen collection
Active Awarded Last action
- Contract number
- 75N91020F00030
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $37,727,154
Award facts
- Contract value 100% obligated
- $37,727,154.00 Current and potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $7,308,447 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $7,228,351 | |
| Exercise an Option | $7,372,801 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,996,530 | |
| Original award | $7,821,025 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2020, with a ceiling value of $37.7 million for CPTAC biospecimen collection, with ultimate completion on August 30, 2027.
Leidos Biomedical Research Inc. is an FFRDC contractor subsidiary of Leidos Holdings, Inc., serving as the National Cancer Institute's primary biomedical research support provider. Place of performance is Frederick, Maryland.
The order is cost-plus-fixed-fee with no set-aside designation. Service Contract Inventory data shows government-invoiced labor across five fiscal years: FY2020 invoiced $407 thousand; FY2021 invoiced $4.8 million across 14.5 FTEs and 30,069 contractor hours at $159.73 per hour; FY2022 invoiced $5.7 million across 8.4 FTEs and 17,534 contractor hours at $323.02 per hour; FY2023 invoiced $6 million across 19.6 FTEs and 40,747 contractor hours at $148.31 per hour; FY2024 invoiced $4.8 million across 19.5 FTEs and 40,493 contractor hours at $117.91 per hour. The derived government-paid hourly rate has declined year-over-year from FY2021 through FY2024. In FY2024, 70 percent of contractor hours were subcontracted out across seven named subcontractors.
Quick answers
Who was awarded contract 75N91020F00030?
75N91020F00030 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2020.
How much is contract 75N91020F00030 worth?
The government has obligated $37,727,154 on 75N91020F00030.
Is contract 75N91020F00030 an order under another contract?
Yes. 75N91020F00030 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00030 competed?
The extent of competition for 75N91020F00030 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award